05/22/2024
5:17 PM | Gangolli Julian S (Reporting)
Krystal Biotech (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/21/2024
3:38 PM | Krystal Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/20/2024
3:51 PM | Gangolli Julian S (Reporting)
Krystal Biotech (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/06/2024
7:04 AM | Krystal Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/06/2024
7:17 AM | Krystal Biotech (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/04/2024
3:08 PM | Krystal Biotech (Filer)
| Form DEF 14A | |
04/04/2024
3:09 PM | Krystal Biotech (Filer)
| Form DEFA14A | |
|
03/11/2024
7:24 PM | Krishnan Krish S (Reporting)
Krystal Biotech (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
7:27 PM | Krishnan Suma (Reporting)
Krystal Biotech (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
3:36 PM | Krishnan Krish S (Reporting)
Krystal Biotech (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/11/2024
3:37 PM | Krishnan Suma (Reporting)
Krystal Biotech (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/01/2024
7:20 PM | Krystal Biotech (Issuer)
ROMANO KATHRYN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/01/2024
7:09 PM | Krishnan Krish S (Reporting)
Krystal Biotech (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/01/2024
7:13 PM | Krishnan Suma (Reporting)
Krystal Biotech (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/01/2024
7:16 PM | Krystal Biotech (Issuer)
ROMANO KATHRYN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/28/2024
8:39 PM | Krishnan Suma (Reporting)
Krystal Biotech (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/28/2024
8:33 PM | Krystal Biotech (Issuer)
ROMANO KATHRYN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/28/2024
8:36 PM | Krishnan Krish S (Reporting)
Krystal Biotech (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/26/2024
12:35 PM | Krystal Biotech (Subject)
ROMANO KATHRYN (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/26/2024
6:59 AM | Krystal Biotech (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/26/2024
7:04 AM | Krystal Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/26/2024
6:49 AM | Krystal Biotech (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/14/2024
8:25 AM | Avoro Capital Advisors LLC (Filed by)
Krystal Biotech (Subject)
| Form SC 13G/A | |
01/29/2024
2:26 PM | Krystal Biotech (Subject)
| Form SC 13G/A | |
01/24/2024
4:44 PM | Krystal Biotech (Issuer)
Romano Kathryn (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/22/2024
10:43 AM | Krystal Biotech (Subject)
Romano Kathryn (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/12/2023
4:17 PM | Krishnan Krish S (Reporting)
Krystal Biotech (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/12/2023
4:23 PM | Krishnan Suma (Reporting)
Krystal Biotech (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/11/2023
3:19 PM | Krishnan Krish S (Reporting)
Krystal Biotech (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/11/2023
3:20 PM | Krishnan Suma (Reporting)
Krystal Biotech (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/06/2023
6:08 AM | Krystal Biotech (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/06/2023
6:10 AM | Krystal Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/02/2023
11:07 AM | Krystal Biotech (Subject)
ORTH ANDREW C. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/12/2023
4:59 PM | Krishnan Krish S (Reporting)
Krystal Biotech (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/12/2023
5:01 PM | Krishnan Suma (Reporting)
Krystal Biotech (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/11/2023
3:16 PM | Krishnan Suma (Reporting)
Krystal Biotech (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/11/2023
3:16 PM | Krishnan Krish S (Reporting)
Krystal Biotech (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/21/2023
4:30 PM | Krystal Biotech (Subject)
ORTH ANDREW C. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/16/2023
3:57 PM | Krystal Biotech (Subject)
ORTH ANDREW C. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/15/2023
3:56 PM | Krystal Biotech (Subject)
ORTH ANDREW C. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/10/2023
5:06 PM | Krystal Biotech (Subject)
ORTH ANDREW C. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
Nvidia is Pivoting to Solve Big Tech’s $1 Trillion Problem (Ad) Taiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as 4,744%.
Now, if you’re like everybody else, you want to know what Nvidia’s doing next … and who they’re going to partner with … Find out details on these three critical Nvidia partners immediately. |
08/07/2023
7:18 AM | Krystal Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/07/2023
6:07 AM | Krystal Biotech (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/07/2023
6:13 AM | Krystal Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/18/2023
3:05 PM | Krystal Biotech (Filer)
| Form S-3ASR | |
07/03/2023
3:35 PM | Krystal Biotech (Issuer)
Mazzacco Catherine (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2023
3:20 PM | JANNEY DANIEL (Reporting)
Krystal Biotech (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2023
3:24 PM | Krystal Biotech (Issuer)
Mason Christopher (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2023
3:27 PM | Krystal Biotech (Issuer)
ROSSI DINO A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2023
3:31 PM | Krystal Biotech (Issuer)
Sutherland Everett Rand (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2023
3:16 PM | Gangolli Julian S (Reporting)
Krystal Biotech (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/09/2023
6:00 PM | Krystal Biotech (Issuer)
ORTH ANDREW C. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/09/2023
6:03 PM | JANNEY DANIEL (Reporting)
Krystal Biotech (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/02/2023
5:21 PM | Krishnan Krish S (Reporting)
Krystal Biotech (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/02/2023
5:23 PM | Krishnan Suma (Reporting)
Krystal Biotech (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/31/2023
3:23 PM | Krishnan Suma (Reporting)
Krystal Biotech (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
